This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

7 Mar 2013

TransTech Pharma looking forward to Phase III clinical trials for TTP488

TransTech Pharma is looking forward to undertaking Phase III clinical trials to examine how effective TTP488 can be in the treatment of Alzheimer's disease.


A clinical-stage pharmaceutical company has completed its end of Phase II meeting for TTP488 (a small-molecule compound) with the US Food and Drug Administration (FDA).

Related News